High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning
Background Glucocorticosteroids (GC) are long-established, widely used agents for induction of remission in inflammatory bowel disease (IBD). Hyperglycaemia is a known complication of GC treatment with implications for morbidity and mortality. Published data on prevalence and risk factors for GC-ind...
Main Authors: | Florina Borca, Martin McDonnell, Suranga Dharmasiri, Tilly Mills, Mayank Patel, Richard J Harris, Benjamin Zare, Matt Stammers, Hang T T Phan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000532.full |
Similar Items
-
Glucocorticoid induced hyperglycaemia
by: M I Weerakkody, et al.
Published: (2012-05-01) -
On adrenalin hyperglycaemia
by: Affleck, A. M.
Published: (1928) -
Zuogui Jiangtang Jieyu Formulation Prevents Hyperglycaemia and Depressive-Like Behaviour in Rats by Reducing the Glucocorticoid Level in Plasma and Hippocampus
by: YuHong Wang, et al.
Published: (2015-01-01) -
Managing hyperglycaemia in hospitalized patients
by: Uditha Bulugahapitiya
Published: (2012-10-01) -
Hyperglycaemia in criticaly ill patients
by: Tatiana Valer'evna Klypa, et al.
Published: (2015-03-01)